Enhancement of leptin receptor signaling by SOCS3 deficiency induces development of gastric tumors in mice

Oncogene

Volumn 33, Issue 1, 2014, Pages 74-84

  Inagaki Ohara, K ^a,b,c   Mayuzumi, H ^a   Kato, S ^a   Minokoshi, Y ^b   Otsubo, T ^c   Kawamura, Y I ^c   Dohi, T ^c   Matsuzaki, G ^a   Yoshimura, A ^d  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^c National Center for Global Health and Medicine   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

gastric tumor; leptin; SOCS3

Indexed keywords

BETA CATENIN; LEPTIN; LEPTIN RECEPTOR; LEUKEMIA INHIBITORY FACTOR; MUCIN 2; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE DELETION; HYPERPLASIA; INFLAMMATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; STOMACH LESION; STOMACH MUCOSA; STOMACH TUMOR; TUMOR GROWTH;

LOTUS; MUS;

EID: 84891740143     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.540     Document Type: Article

References (53)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432. (Pubitemid 24365442)
2. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770. (Pubitemid 28485436)
3. Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 1996; 6: 1170-1180. (Pubitemid 26368751)
4. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001; 33: 95-102. (Pubitemid 32655888)
5. La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol 2004; 4: 371-379. (Pubitemid 38649279)
6. Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN et al. The stomach is a source of leptin. Nature 1998; 394: 790-793. (Pubitemid 28391644)
7. Sobhani I, Bado A, Vissuzaine C, Buyse M, Kermorgant S, Laigneau JP et al. Leptin secretion and leptin receptor in the human stomach. Gut 2000; 47: 178-183. (Pubitemid 30489759)
8. Morton NM, Emilsson V, Liu YL, Cawthorne MA. Leptin action in intestinal cells. J Biol Chem 1998; 273: 26194-26201. (Pubitemid 28475857)
9. Buyse M, Berlioz F, Guilmeau S, Tsocas A, Voisin T, Peranzi G et al. PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J Clin Invest 2001; 108: 1483-1494. (Pubitemid 33091986)
10. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M et al. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. Faseb J 2000; 14: 2329-2338.
11. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-1271. (Pubitemid 26007816)
12. Bjorbaek C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997; 272: 32686-32695. (Pubitemid 28011961)
13. Mix H, Widjaja A, Jandl O, Cornberg M, Kaul A, Goke M et al. Expression of leptin and leptin receptor isoforms in the human stomach. Gut 2000; 47: 481-486.
14. Ishikawa M, Kitayama J, Nagawa H. Expression pattern of leptin and leptin receptor (OB-R) in human gastric cancer. World J Gastroenterol 2006; 12: 5517-5522. (Pubitemid 44501812)
15. Bjorbak C, Lavery HJ, Bates SH, Olson RK, Davis SM, Flier JS et al. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem 2000; 275: 40649-40657. (Pubitemid 32064706)
16. Eyckerman S, Broekaert D, Verhee A, Vandekerckhove J, Tavernier J. Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor. FEBS Lett 2000; 486: 33-37.
17. Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 1999; 274: 30059-30065.
18. Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998; 1: 619-625. (Pubitemid 128374698)
19. Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to dietinduced obesity. Nat Med 2004; 10: 739-743. (Pubitemid 38937640)
20. Zhao X, Huang K, Zhu Z, Chen S, Hu R. Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer. J Gastroenterol Hepatol 2007; 22: 1317-1321. (Pubitemid 47222662)
21. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S. Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol 2007; 60: 902-906. (Pubitemid 47234437)
22. Feldman DE, Chen C, Punj V, Tsukamoto H, Machida K. Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells. Proc Natl Acad Sci USA 2012; 109: 829-834.
23. Sitaraman S, Liu X, Charrier L, Gu LH, Ziegler TR, Gewirtz A et al. Colonic leptin: source of a novel proinflammatory cytokine involved in IBD. FASEB J 2004; 18: 696-698.
24. Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R et al. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut 2010; 59: 227-235.
25. Rigby RJ, Simmons JG, Greenhalgh CJ, Alexander WS, Lund PK. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon. Oncogene 2007; 26: 4833-4841. (Pubitemid 47093177)
26. Banks AS, Davis SM, Bates SH, Myers Jr MG. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 2000; 275: 14563-14572. (Pubitemid 30339746)
27. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
28. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005; 8: 197-209. (Pubitemid 41317591)
29. Rosivatz E, Becker KF, Kremmer E, Schott C, Blechschmidt K, Hofler H et al. Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch 2006; 448: 277-287. (Pubitemid 43357643)
30. Montero C, Segura DI. Retrospective histochemical study of mucosubstances in adenocarcinomas of the gastrointestinal tract. Histopathology 1980; 4: 281-291. (Pubitemid 10062983)
31. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
32. Suh E, Traber PG. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol 1996; 16: 619-625. (Pubitemid 26029101)
33. Kim BM, Buchner G, Miletich I, Sharpe PT, Shivdasani RA. The stomach mesenchymal transcription factor Barx1 specifies gastric epithelial identity through inhibition of transient Wnt signaling. Dev Cell 2005; 8: 611-622. (Pubitemid 40450749)
34. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867. (Pubitemid 36019639)
35. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008; 13: 206-220. (Pubitemid 351318372)
36. Wu L, Du H, Li Y, Qu P, Yan C. Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis. Am J Pathol 2011; 179: 2131-2141.
37. He Y, Chen H, Quon MJ, Reitman M. The mouse obese gene. Genomic organization, promoter activity, and activation by CCAAT/enhancer-binding protein alpha. J Biol Chem 1995; 270: 28887-28891.
38. Zhang Y, Sif S, DeWille J. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression. J Cell Biochem 2007; 102: 1256-1270. (Pubitemid 350220046)
39. Howard JM, Pidgeon GP, Reynolds JV. Leptin and gastro-intestinal malignancies. Obes Rev 2010; 11: 863-874.
40. Zhao L, Shen ZX, Luo HS, Shen L. Possible involvement of leptin and leptin receptor in developing gastric adenocarcinoma. World J Gastroenterol 2005; 11: 7666-7670. (Pubitemid 43168434)
41. Guilmeau S, Buyse M, Bado A. Gastric leptin: a new manager of gastrointestinal function. Curr Opin Pharmacol 2004; 4: 561-566. (Pubitemid 40267869)
42. Cinti S, Matteis RD, Pico C, Ceresi E, Obrador A, Maffeis C et al. Secretory granules of endocrine and chief cells of human stomach mucosa contain leptin. Int J Obes Relat Metab Disord 2000; 24: 789-793. (Pubitemid 30339279)
43. Stringer EJ, Pritchard CA, Beck F. Cdx2 initiates histodifferentiation of the midgut endoderm. FEBS Lett 2008; 582: 2555-2560.
44. Nduati V, Yan Y, Dalmasso G, Driss A, Sitaraman S, Merlin D. Leptin transcriptionally enhances peptide transporter (hPepT1) expression and activity via the cAMP-response element-binding protein and Cdx2 transcription factors. J Biol Chem 2007; 282: 1359-1373. (Pubitemid 47076560)
45. Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H et al. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 2008; 118: 1727-1738. (Pubitemid 351632376)
46. Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M, Giraud AS. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 2006; 131: 1073-1085. (Pubitemid 44498694)
47. Kidder BL, Yang J, Palmer S. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS ONE 2008; 3: e3932.
48. Cascio S, Ferla R, D'Andrea A, Gerbino A, Bazan V, Surmacz E et al. Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. J Cell Physiol 2009; 221: 189-194.
49. Aihara H, Hiwatashi N, Kumagai S, Obata Y, Shimosegawa T, Toyota T et al. The T3(b) gene promoter directs intestinal epithelial cell-specific expression in transgenic mice. FEBS Lett 1999; 463: 185-188. (Pubitemid 30001744)
50. Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 2003; 4: 551-556. (Pubitemid 36701338)
51. Inagaki-Ohara K, Sasaki A, Matsuzaki G, Ikeda T, Hotokezaka M, Chijiiwa K et al. Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice. Gut 2006; 55: 212-219. (Pubitemid 43117281)
52. Inagaki-Ohara K, Sakamoto Y, Dohi T, Smith AL. gd T cells play a protective role during infection with Nippostrongylus brasiliensis by promoting goblet cell function in the small intestine. Immunology 2011; 134: 448-458.
53. Inagaki-Ohara K, Chinen T, Matsuzaki G, Sasaki A, Sakamoto Y, Hiromatsu K et al. Mucosal T cells bearing TCR gd play a protective role in intestinal inflammation. J Immunol 2004; 173: 1390-1398. (Pubitemid 38924320)